Widmann Associates

Widmann Associates is a premier strategic consulting firm specializing in market access, pricing, and reimbursement for the global pharmaceutical and biotechnology sectors. The firm is recognized for its deep expertise in navigating complex payer environments, particularly for high-value specialty therapeutics in oncology and rare diseases. By providing data-driven insights and strategic frameworks, Widmann Associates helps life science companies optimize the commercial potential and patient access for their innovative therapies. In July 2014, the company was acquired by Precision for Value, a division of Precision Medicine Group, to enhance their integrated market access and payer marketing capabilities. Today, the legacy of Widmann Associates continues through its integration into Precision's broader suite of commercialization services.